Vitrolife
Vitrolife AB, headquartered in Sweden, is a leading player in the reproductive health industry, specialising in products and services for assisted reproductive technology (ART). Founded in 1994, the company has established a strong presence in key operational regions, including Europe, North America, and Asia. Vitrolife is renowned for its innovative solutions, including culture media, cryopreservation products, and laboratory equipment designed to enhance the success rates of IVF treatments. Their commitment to quality and research has positioned them as a trusted partner for fertility clinics worldwide. With a focus on advancing reproductive medicine, Vitrolife continues to achieve significant milestones, solidifying its reputation as a pioneer in the field.
DitchCarbon Score
How does Vitrolife's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Vitrolife's score of 38 is higher than 97% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Vitrolife's reported carbon emissions
In 2023, Vitrolife reported total carbon emissions of approximately 19,736,000 kg CO2e, with emissions distributed across Scope 1, Scope 2, and Scope 3. Specifically, Scope 1 emissions were about 727,000 kg CO2e, Scope 2 emissions totalled approximately 1,360,000 kg CO2e, and Scope 3 emissions accounted for around 19,736,000 kg CO2e. Over the previous years, Vitrolife's emissions have shown a consistent pattern, with Scope 3 emissions being significantly higher than those from Scopes 1 and 2. For instance, in 2021, Scope 3 emissions reached about 19,736,000 kg CO2e, while Scope 1 and Scope 2 emissions were approximately 727,000 kg CO2e and 1,360,000 kg CO2e, respectively. Vitrolife is committed to reducing its carbon footprint, having established near-term reduction targets, although it has not yet committed to a net-zero target. The company operates within the healthcare equipment and supplies sector and is based in Sweden. As of October 2023, it remains focused on enhancing its sustainability practices and reducing emissions across its operations.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 515,000 | 000,000 | 000,000 | 000,000 |
| Scope 2 | 702,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 1,199,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Vitrolife is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
